Can You Take Codeine with Midazolam?
A plain-English look at the major interaction between Codeine (Aspen Pharmacare Australia Pty Ltd) and Midazolam (Pfizer Australia Pty Ltd) — what it means, why it happens, and what to talk to your doctor or pharmacist about.
Taking Codeine (Aspen Pharmacare Australia Pty Ltd) with Midazolam (Pfizer Australia Pty Ltd) is a major drug interaction that should be avoided. Life-threatening respiratory depression, overdose, coma, and death. Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.
Not sure about your specific combination? Check it in the Drug Interaction Checker →
Key Takeaways
- Interaction severity: Major
- Risk: Life-threatening respiratory depression, overdose, coma, and death.
- Mechanism: Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.
- Codeine: S8 in Australia, moderate risk
- Midazolam: S4 in Australia, moderate risk
- Claims action: Flag for immediate prescriber review. Document intervention in claim file.
Codeine vs Midazolam at a Glance
| Property | Codeine | Midazolam |
|---|---|---|
| Brand names | Aspen Pharmacare Australia Pty Ltd | Pfizer Australia Pty Ltd, Zyamis |
| Drug class | opioid | benzo |
| Risk level | moderate | moderate |
| TGA Schedule (AU) | S8 | S4 |
Why Is This Combination Dangerous?
Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.
Regulatory Guidance by Jurisdiction
Australia TGA / SIRA / WorkSafe
The TGA and Australian Medicines Handbook classify this as a major drug interaction requiring immediate intervention.
All Australian state workers compensation schemes (SIRA NSW, WorkSafe VIC, WorkCover QLD) flag concurrent opioid and benzodiazepine prescribing as high-risk. SIRA best practice guidelines explicitly recommend avoiding this combination except in exceptional circumstances with specialist oversight.
United Kingdom NICE / MHRA / FPM
NICE NG193 (Chronic Pain) recommends against initiating opioids for chronic primary pain. The Faculty of Pain Medicine (FPM) Opioids Aware guidelines strongly advise against concurrent opioid and benzodiazepine prescribing. For personal injury claims in the UK, this combination should be flagged for specialist review. Costs for medication review may be recoverable as a disbursement.
United States FDA / CDC / State WC
The FDA requires a Boxed Warning on all opioid and benzodiazepine products about the risks of concurrent use. The CDC Clinical Practice Guideline (2022) recommends clinicians avoid prescribing opioids and benzodiazepines concurrently whenever possible. Most state workers compensation drug formularies flag or restrict this combination.
What Claims Professionals Should Do
- Flag immediately as a high-risk prescribing pattern in the claim file
- Request urgent prescriber review with documented clinical justification for the combination
- Consider an independent medical examination if the prescriber cannot provide adequate justification
- Assess work capacity impact as the combination significantly increases sedation and impairment risk
- Document all interventions for audit trail and compliance purposes
- Check Reasonable and Necessary status for both medications against the compensable injury
Check this medication against your full medication list
Check all interactions for Codeine and Midazolam across your claimant's full medication list.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Related Resources
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.